Metastasis to the skin from lung cancer is less commonthan metastasis to other organs. We clinically reviewed 16 cases of skin metastasis. The incidence of skin metastasis was 2.8% among all 579 cases of lung cancer. Large cell carcinoma showed the greatest tendency to spread to the skin and epidermoid carcinoma showedthe least tendency. The most commonsites for skin lesions were the back. Almost all lesions ranged from 1 to 5 cm in diameter. Clinical manifestation of skin metastasis was nodular type in all cases. At the development of skin metastasis, all cases were accompaniedby metastasis to other organs. There was only a slight response to combination chemotherapy carried out 5 cases for lung cancer, and most lesions were progressive. Median survival after skin involvement was approximately 4 months. (Internal Medicine 35: 459-462, 1996) 
Introduction
In the 1970s, Brownstein and Helwig reported that lung cancer as well as breast cancer werethe mostcommon cancers to metastasize to the skin (1, 2) . Since 1993, the mortality from lung cancer has been the highest for malignancies in Japan, and recently it has been reported to be the most commoninternal malignancy to metastasize to the skin. However,in cases of lung cancer, metastasis to the skin is less commonthan that to other organs (brain, bones, liver, and adrenal glands) and the reported incidence ranges from 1 to 12% (3) (4) (5) (6) (7) (8) . Werecognized that lung cancer may be initially detected by cutaneous metastasis, since the primary lung lesion often remains quiescent. Therefore, we reviewed 16 cases of skin metastasis from lung cancer admitted to Jichi Medical School Hospital between 1 984 and 1993 and discussed their clinical features.
Patients and Methods
In this study, 16 cases of skin metastasis among579 cases diagnosed as lung cancer and admitted to Jichi Medical School Hospital between 1984 and 1993 forexamination. Wereviewed their clinical features including incidence, age, gender, chief complaints, location of metastases, number of skin metastases, presence of metastases to other organs, response to treatment and prognosis.
Results
The incidence ofmetastasis to the skin was 2.8% among all patients with lung cancer (579 cases), with males 3.0% (14/464 cases), and females 1.7% (2/1 15 cases). The mean age of these 16 cases was 62.8 years and the range was from 36 to 82 years (Tables 1, 2) . Of 579 cases, adenocarcinoma was found in 44.6%, epidermoid carcinoma 32.6%, small cell carcinoma 15.7%, large cell carcinoma 5.0%, and other types 2.1%. The histological patterns in patients with skin metastasis, were large cell carcinoma, 10.3% (3/29 cases), adenocarcinoma, 3.1% (8/ 258 cases), small cell carcinoma, 2.2% (2/91 cases), epidermoid carcinoma, 1.5% (2/189 cases), and other types, 8.3%. Large cell carcinoma showed the greatest tendency to spread to the skin whereas epidermoidcarcinoma showedthe least tendency ( Fig. 1 ).
Chief complaints were respiratory symptoms in 7 cases, including cough, hemosputum, and dyspnea. Five cases of them already had skin metastasis on admission, but they had no dermal symptoms. Three patients complained of dermal symptoms, such as tenderness or a lump. Other 6 cases showed general fatigue, chest pain, and lumbago due to bone metastasis. Regarding the number of skin metastases, 4 cases had a single location, 9 cases from 2 to 5 locations, and 3 cases had more than 6 locations. Multiple skin metastases (more than 2 locations) occurred in 75%. The most commonlocations for skin lesions were the back, abdomen, and anterior part of the chest. Large cell carcinoma frequently metastasized to multiple locations. In size, almost all lesions ranged from 1 to 5 cmin Vindesine, Etoposide, and Carboplatin. Five cases showed little response to chemotherapy. In case 12, the drugs suppressed the growth of tumor during chemotherapy but the tumor grew gradually after chemotherapy was discontinued. In 2 other cases, radiotherapy was performed for skin metastatic lesions and the tumors were reduced for a while. Survival prognosis after skin metastasis was from 1 to 19 monthsand the median survival time was 4 months. In 3 patients, the average survival time from diagnosis of skin metastasis was approximately 16 months.
Nosignificant relationship was found between histological type and incidence, number, size of skin lesion, number of other metastatic organs (%2-test), or median survival time (generalized Wilcoxon test).
Discussion
Skin metastasis from internal malignancy is rare and the incidence is reported to be between 1.4% and 6.7% (2, 3, 8) . In Japan, the common primary malignancy of skin metastasis are reported to be stomach, breast, and lung (3, (9) (10) (11) (12) . Recently, skin metastasis from lung cancer has been most frequently reported because of the increase in lung cancer, and due to early detection and treatment of gastric cancer ( 1 2). Regarding, skin metastasis from lung cancer, the incidence was reported to be 1.7 to 4.0% inJapan (4, 8) and 1 to 12% in othercountries (3, (5) (6) (7) 9) . Our result (2.8%) is comparable to these findings. Regarding the histological patterns in skin metastasis, large cell carcinoma showedthe greatest tendency to spread to the skin, 10.3% (3/29 cases), while in epidermoid carcinoma, only 1.5%
(2/1 89 cases) developed cutaneous metastasis. However, there was no significant difference in the incidence of skin metastasis among histological types. Although the investigation of the incidence by every histological type involved few cases in this study. These results weresimilar to those in the review of Terashima and Kanazawa (8) . In some reports (1, 2, 4, 7), skin metastasis from adenocarcinoma showedthe greatest tendency while that from large cell carcinoma showed the least. Thus, which histological type has highest incidence of skin metastasis has not yet been established. The greater number of chief complaints involved respiratory symptoms, including cough, hemosputum and so on, and skin symptoms were few. Five of 7 cases who had respiratory symptomsalready had skin metastasis on admission, but they
Internal Medicine Vol. 35, No. 6 (June 1996) had no dermal symptoms. Manyreviews by dermatologists noted chief complaints involving skin symptomsin approximately 20-40% in metastatic skin cancer cases (8, 10) , however, in the present study only 3 patients (18.8%) had complaints related to the skin. Gembaet al reported that none of the patients in his series complained of dermal symptomsat the initial examination (4). Thus, the internists' reviews do not concur with dermatologists' studies (8, 10) . Clinical manifestations of skin metastases were classified as nodular, inflammatory, and sclerodermoid metastatic lesion by Brownstein and Helwig (1) . Generally, the nodular type is the result of hematogenous metastasis, and is likely to be most commonand multiple (3, 4, 12) . All of our cases involved the nodular type and 75% of our patients had multiple lesions. Most lesions were round and firm, raised and hemispherical, covered by an intact epidermis, while two cases had ulcerated lesions. Atthe time of development of skin metastasis, 15 of 16 cases demonstrated accompanying metastasis to other organs, those were bone, brain, lung, and liver. So skin involvement as a sole presenting symptomof lung cancer appears to be rare. These results could support the poor prognosis with skin metastasis.
As metastasis tends to occur mainly near the primary tumor (2, 4, 5, 1 1, 13), the most commonsites of the skin lesion were the anterior part of the chest, back, and abdomen. Metastases to these sites have been noted relatively frequently by other authors (4, 6-8, 10, 13), but there were few scalp lesions, although these have been commonbecause of the rich blood flow and the incidence noted by Brownstein and others (10) (11) (12) was 54%.
For treatment, 5 cases received combined chemotherapy, and 2 cases underwent radiotherapy. Wenoted that chemotherapy was less effective for skin lesions than for primary lesions. The prognosis for patients with skin metastasis from lung cancer is very poor because, in general, their disease is advanced, and the involvement of other organs such as brain, liver, bones, and adrenal glands is usually manifest. The mean survival prognosis after skin metastasis was reported to be poor, approximately 4 to 6 months (1, 6, ll). The median survival time after skin metastasis was 4 months. In our study, the average survival time of 3 patients was approximately 16 months. In one case, the tumor mayhave been suppressed by drugs during chemotherapy, but the other two cases had multiple metastases and showedlittle response, although they had slightly better prognoses. In fact, the prognosis of lung cancer with skin metastasis has been reported to be poor, although some reports (4, 8, 1 1) andthepresent study showed some cases with a slightly better prognosis. Someof them had few metastasis to other organs. In such cases, further comprehensive analysis is needed. In conclusion, with the increase in lung cancer, the clinical features of skin metastasis may be changing.
